erzotabart
Generic: Erzotabart
erzotabart: 1 clinical trial tracked.
erzotabart evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about erzotabart, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
Clinical Trial Registry Records (1)
An Open-Label, Multicenter, Phase 1/2 Trial of GEN3014 (HexaBody®-CD38) in Relapsed or Refractory Multiple Myeloma and Other Hematologic Malignancies
Primary endpoint: Dose Escalation: Number of Participants With Dose Limiting Toxicities (DLTs)
InterventionalRandomizedopen130 targetStarted 2021-03Completion 2025-0750 sites · Australia, Bosnia and Herzegovina, Czechia, Denmark…Genmab